International audience
-
December 23, 2016 (v1)Journal articleUploaded on: December 3, 2022
-
November 19, 2022 (v1)Publication
Abstract Lipid droplets are dynamic organelles with a central role in fatty acid metabolism. They protect cells from lipotoxicity by sequestering excess fatty acids but also provide fatty acids for metabolic reactions and signalling events. Here we show that lipid droplet turnover in cancer cells is required for production of ω-3 and ω-6...
Uploaded on: December 3, 2022 -
November 26, 2020 (v1)Journal article
Alternative strategies targeting dysregulated cytokine balance could be considered for these patients at high risk of relapse.
Uploaded on: February 22, 2023 -
September 1, 2021 (v1)Book section
Exciting times for the field of renal autoimmune diseases have begun. In 2021, for the first time, two new drugs belimumab (1) and voclosporin ( 2) are approved for the treatment of lupus nephritis (LN) (1, 2). Other novel targeted therapies demonstrate clinical efficacy in large, randomized trials, such as avacopan for ANCA-associated...
Uploaded on: December 4, 2022 -
November 26, 2020 (v1)Journal article
Alternative strategies targeting dysregulated cytokine balance could be considered for these patients at high risk of relapse.
Uploaded on: December 4, 2022 -
2020 (v1)Journal article
Background and objectives Patients with membranous nephropathy can have circulating autoantibodies against membrane-bound (phospholipase A2 receptor 1 [PLA2R1] and thrombospondin type-1 domain containing 7A [THSD7A]) and intracellular (aldose reductase, SOD2, and α-enolase) podocyte autoantigens. We studied their combined association with...
Uploaded on: December 4, 2022 -
October 2023 (v1)Journal article
International audience
Uploaded on: November 25, 2023 -
December 30, 2019 (v1)Journal article
The phospholipase A2 receptor (PLA2R1) is the major autoantigen in idiopathic membranous nephropathy (MN). However, the pathogenic role of anti-PLA2R1 autoantibodies is unclear. Our aim was to evaluate the in vitro cytotoxicity of anti-PLA2R1 antibodies mediated by complement. Forty-eight patients with PLA2R1-related MN from the prospective...
Uploaded on: December 4, 2022 -
November 2023 (v1)Journal article
International audience
Uploaded on: December 6, 2023 -
September 2024 (v1)Journal article
IntroductionMembranous nephropathy can lead to end-stage kidney disease, for which kidney transplantation is the preferred therapy. However, the disease often relapses, which can impact allograft survival.MethodsWe conducted a prospective multicenter study in France involving 72 patients with membranous nephropathy who were awaiting and then...
Uploaded on: September 27, 2024